Connect with us

Government

China Is Still Miles Behind Phase 1 Trade Deal Targets

China Is Still Miles Behind Phase 1 Trade Deal Targets
Tyler Durden
Wed, 12/16/2020 – 21:30

By Michiel van der Veen

Phase One Monitor: A December Update

Summary

Despite reversing the downward trend in September and October, China is still.

Published

on

China Is Still Miles Behind Phase 1 Trade Deal Targets Tyler Durden Wed, 12/16/2020 - 21:30

By Michiel van der Veen

Phase One Monitor: A December Update

Summary

  • Despite reversing the downward trend in September and October, China is still miles behind the target of USD 230bn set out for imports of US goods and services in 2020
  • China already fell short by USD 78 billion in the first 10 months of 2020 and only has two months to crank up imports by an additional USD 104 billion
  • There is a clear divergence on the progress towards targets for agricultural and energy imports, and manufacturing and services imports.
  • We expect that the future Biden administration will not adopt a softened stance on US trade with China
  • Before the inauguration ceremony in January, Trump might pull the plug from the Phase One deal to cement his legacy as being the ‘only president that stood up against China’
  • China is preparing for further bilateral tensions by adopting an export control law

China is still miles behind target

This report provides an update of our Phase One Monitor (POM), which keeps track of China’s progress towards the targets set out in in the Phase One trade deal signed in January 2020. Specifically, China pledged to import an additional USD 200 billion worth of US goods and services by 2021 (compared to 2017 levels).

Despite reversing the downward trend in September and October, China is still miles behind the target of USD 230bn set for imports of US goods and services in 2020 (Figure 1). Between October 2019 and October 2020, China imported USD 125bn of goods and services covered by the Phase One deal.1 This means China already fell short by USD 78bn in the first 10 months of 2020 and only has two months to crank up the import of goods and services by USD 104bn. Given that the year is almost out, it seems all but impossible that China will reach the 2020 target for imports of US goods and services.

Developments by product group

When shifting our focus to the individual product groups, we observe diverging trends. Agricultural and energy imports are closing in on the target, while manufacturing imports have been stagnant and services imports are even exhibiting a downtrend.

Energy and agriculture

China’s import of US energy products maintained upward momentum (increasing from USD 6.1bn to 7.3bn) but is still far off the USD 24bn target set for 2020 (Figure 2). The increase in US energy exports to China is mainly driven by crude oil (Figure 3). China’s ramping up on oil is closely linked to the recovery from the COVID-19 crisis. But it could also be explained by China’s strategic goal of becoming more self-reliant, which requires stockpiling of commodities that China lacks.

China’s demand for US agricultural goods also increased significantly in September and October to USD 22bn, but this too is well below the target agreed upon in the Phase One deal (of USD 33bn, see Figure 4). A substantial percentage of China’s higher imports of US agricultural goods is driven by soybean import (Figure 5). Demand for US soybeans slipped in 2018 and 2019 when China’s pig herd was struck by African swine fever. Soybean exports reached peak levels seen before 2018 despite the herd rebuilding was in very good progress. China also started to import more other agricultural products, such as grains and cotton. Ultimately, from the perspective of energy and agricultural goods, we clearly see that China is making an effort to follow up on the agreements in the Phase One deal.

Manufacturing and services

China has made little progress towards the target when it comes to imports of US services and manufacturing goods (Figure 6 and 7). Annual US manufacturing exports (USD 56bn) to China are still below the level seen before the Phase One deal was signed. Import of US aircrafts (both order and deliveries) and vehicles have contracted since the deal was signed at the beginning of the year, although the decline in vehicle trade seems to have bottomed out.

On the services front, the trend is the diametric opposite of what it should have been (Figure 7). The annual services import currently stands at USD 40bn, whereas the ultimo 2020 target in the Phase One deal stands at USD 70bn. Admittedly, total US services exports have decreased steeply this year during the corona crisis. Yet, US services exports to China fell even more in Q3 (Figure 9). This is at the least remarkable given the fact that China seems to be closest to a pre-pandemic economy.

Looking ahead

The White House will soon welcome a new resident, but we do not expect the US administration under president Biden to adopt a softened stance on trade with China. There is bipartisan opposition against China’s trade practices. In a recent interview, Biden already stated that he will push back on issues such as intellectual property theft, subsidies to state-owned enterprises and forced technology transfers. He also said he will not immediately roll back tariffs on Chinese goods that were imposed by the Trump administration. Neither is he planning to immediately revoke the Phase One deal that was signed at the beginning of 2020 between the US and China. Beijing has signaled that it wants to renegotiate the Phase One deal when Biden is inaugurated as president, as the import targets in the deal are perceived as unrealistic.

Will Trump pull the plug?

There is still a chance that Biden will not even have to decide the fate of the Phase One trade deal. China’s inability to live up to its trade promises in the Phase One deal is the perfect opportunity for Trump to launch a final protectionist push towards China in the final weeks of his presidency. True, agricultural commodity prices (especially soybeans) are at multi-year highs, which means the Phase One deal is probably regarded favorably amongst one of Trump’s core constituencies. That being said, pulling the plug on the trade deal would fit the scorched-earth strategy that Trump has already initiated by, e.g. banning investment in 89 Chinese companies and the travel visa restrictions for Chinese Communist Party (CCP) members from 10 years to one month and single entry.

The motivation for Trump to strike a final blow against China is that it will cement his legacy as being the ‘only president that stood up against China’. The President runs the risk that Biden will keep the Phase One deal alive and showcase its (future) success as a Democratic achievement. In any case, the tough-on-China stance resonates well with US voters. Moreover, it might give one of his children a head start if they run in later election cycles. Note that both Donald Trump Jr. and Ivanka Trump are popular among Republicans as candidates for future presidential elections.

China is preparing for further escalation of trade tensions

Meanwhile, China is also preparing for a further escalation of US-China trade tensions. On December 1, a new export control law came into force in China which grants Beijing power to block exports if it feels that national security or national interests are being threatened. A comprehensive list of goods subject to export controls is not yet available. Even if a product does not end up on the list, China’s government would still be able to impose temporary export controls for up to two years. The export control law could be interpreted as a response to a series of US measures aimed at curbing Chinese tech firms.

Override Early Access
On

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending